Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 21-30 of 34 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2012BiP prevents rod opsin aggregationAthanasiou, D.; Kosmaoglou, M.; Kanuga, N.; Novoselov, S.; Paton, A.; Paton, J.; Chapple, J.; Cheetham, M.; Brodsky, J.L.
2012Absence of O antigen suppresses Shigella flexneri IcsA autochaperone region mutationsTeh, M.; Tran, N.; Morona, R.
2011For all my family's sake, I should go and find out: An Australian report on genetic counseling and testing uptake in individuals at high risk of breast and/or ovarian cancerWakefield, C.; Ratnayake, P.; Meiser, B.; Suthers, G.; Price, M.; Duffy, J.; Tucker, K.
2012Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trialFalchook, G.; Long, G.; Kurzrock, R.; Kim, K.; Arkenau, T.; Brown, M.; Hamid, O.; Infante, J.; Millward, M.; Pavlick, A.; O'Day, S.; Blackman, S.; Curtis, C.; Lebowitz, P.; Ma, B.; Ouellet, D.; Kefford, R.
2012The insulin-like growth factor mutation database (IGFmdb)Rajapaksha, K.; Alvino, C.; McCarthy, P.; Forbes, B.
2011Sensitive detection of BCR-ABL1 mutations in patients with chronic myeloid leukemia after Imatinib resistance is predictive of outcome during subsequent therapyParker, W.; Lawrence, R.; Ho, M.; Irwin, D.; Scott, H.; Hughes, T.; Branford, S.
2012Poor response to second-line kinase inhibitors in chronic myeloid leukemia patients with multiple low-level mutations, irrespective of their resistance profileParker, W.; Ho, M.; Scott, H.; Hughes, T.; Branford, S.
2012Initial molecular response at 3 months may predict both response and event-free survival at 24 months in Imatinib-resistant or -intolerant patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase treated with NilotinibBranford, S.; Kim, D.; Soverini, S.; Haque, A.; Shou, Y.; Woodman, R.; Kantarjian, H.; Martinelli, G.; Radich, J.; Saglio, G.; Hochhaus, A.; Hughes, T.; Muller, M.
2012Identification of a novel pneumococcal vaccine antigen preferentially expressed during meningitis in miceMahdi, L.; Wang, H.; Van der Hoek, M.; Paton, J.; Ogunniyi, A.
2011A variable region within the genome of Streptococcus pneumoniae contributes to strain-strain variation in virulenceHarvey, R.; Stroeher, U.; Ogunniyi, A.; Smith-Vaughan, H.; Leach, A.; Paton, J.; Neyrolles, O.